|Bid||1.7700 x N/A|
|Ask||1.8000 x N/A|
|Day's Range||1.7100 - 1.8300|
|52 Week Range||1.6600 - 8.0000|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 11, 2022 - Apr 15, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.43|
As one of the most controversial initial public offerings (IPOs) in recent memory, Robinhood Markets (NASDAQ:HOOD) basically attempts to become the TD Ameritrade of a new generation. On the basis of brand awareness, the company has arguably succeeded exceptionally. Better yet, despite the boon in the equities sector, you can still pick up Robinhood stocks to buy that are priced below five bucks. Prior to the platform popularizing the concept of gamified investing — or the use of psychologically
Marijuana stocks flat-out floundered in 2021. Making matters worse, the top echelon of Canadian licensed producers all badly missed their own internal financial targets throughout 2021, thanks to stiff competition, changing consumer preferences, lower profit margins, the lack of development in key foreign markets, and poor execution. Curaleaf Holdings (OTC: CURLF) is the largest MSO in the U.S. in terms of annual sales.
Canadian cannabis company Tilray (NASDAQ: TLRY) reported its fiscal 2022 second-quarter earnings results yesterday, and its shares soared. The company surprised investors with a profitable quarter and strong revenue growth. Today, Tilray peer Organigram Holdings (NASDAQ: OGI) also reported solid quarterly results.